CalciMedica, Inc. Retained Earnings
CalciMedica, Inc. (CALC) had Retained Earnings of -$192.00 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$192.00M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$184.35M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$189.33M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$178.57M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$192.00M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$184.35M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$189.33M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | -$178.57M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$170.76M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$164.81M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$159.76M 10-K · filed 2026-03-03 | |
| 2024-09-30 | -$155.51M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$149.89M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$145.93M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$146.06M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$141.92M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$137.30M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | -$131.00M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$111.71M 10-K · filed 2024-03-28 | -$204.79M 10-K · filed 2023-03-09 |
| 2022-09-30 | -$197.39M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$187.58M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$179.34M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$169.19M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$160.51M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$152.52M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$144.82M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$133.37M 10-K · filed 2022-03-11 | |
| 2020-09-30 | -$124.22M 10-Q · filed 2020-11-12 | |
| 2019-12-31 | -$105.84M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |